Vaxart logo

Vaxart Share Price Today (NASDAQ: VXRT)

Vaxart share price is $0.33 & ₹28.29 as on 6 Jul 2025 IST

$0.33

▲

0.01

(3.13%)

Market is closed - opens 7 PM, 10 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 7 Jul 2025

View live Vaxart share price in Dollar and Rupees. Guide to invest in Vaxart stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vaxart, along with analyst recommendations, forecasts, and comprehensive financials.

Vaxart (VXRT) Key Statistics

in dollars & INR

Previous Close
$0.32
Open
$0.417
Market Capitalization
$73.0M
Today's Volume
$23.8M
Revenue TTM
$47.4M
EBITDA
$-48.2M
Earnings Per Share (EPS)
$-0.26
Profit Margin
-122.63%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-114.74%

How to invest in Vaxart Stock (VXRT) from India?

It is very easy for Indian residents to invest directly in Vaxart from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vaxart stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vaxart or VXRT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vaxart or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vaxart shares which would translate to 2.598 fractional shares of Vaxart as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Vaxart, in just a few clicks!

Indian investors sentiment towards Vaxart (VXRT)

1050.0%

Period: Jun 9, 2025 to Jul 9, 2025. Change in 30 Days versus previous period

Investment in Vaxart Shares from India has grown by 1050.0% over the past 30 days, indicating increased transactional activity.

517%

Period: Jun 9, 2025 to Jul 9, 2025. Change in 30 Days versus previous period

Search interest for Vaxart Stock from India on INDmoney has increased by 517% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vaxart

  • Vanguard Group Inc

    4.54%

  • Sio Capital Management, LLC

    2.45%

  • Geode Capital Management, LLC

    1.17%

  • BlackRock Inc

    0.78%

  • Millennium Management LLC

    0.42%

  • Squarepoint Ops LLC

    0.35%

Analyst Recommendation on Vaxart

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vaxart(by analysts ranked 0 to 5 stars)

Vaxart Technicals Summary

Sell

Neutral

Buy

Vaxart is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

About Vaxart

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Organization
Vaxart
Employees
105
CEO
Mr. Steven Lo
Industry
Health Technology

Management People of Vaxart

NameTitle
Mr. Steven Lo
President, CEO & Director
Dr. Sean N. Tucker Ph.D.
Senior VP & Chief Scientific Officer
Dr. James F. Cummings M.D.
Chief Medical Officer
Mr. Jeroen Grasman M.B.A.
CFO, Principal Accounting Officer & Principal Financial Officer
Dr. Raymond D. Stapleton Jr., Ph.D.
Chief Technology Officer
Mr. Edward B. Berg
Senior VP & General Counsel
Ms. Laurie Hastings
Senior Vice President of Human Resources
Ms. Shaily Jaini Garg
Senior Vice President of Clinical Development & Project Management
Dr. Rajesh Kapoor Ph.D.
Senior Vice President of Quality

Important FAQs about investing in VXRT Stock from India :

Can Indians buy Vaxart shares?

Yes, Indians can invest in the Vaxart (VXRT) from India.

With INDmoney, you can buy Vaxart at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vaxart at zero transaction cost.

How can I buy Vaxart shares from India?

It is very easy to buy Vaxart from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vaxart (VXRT) be purchased?

Yes, you can buy fractional shares of Vaxart with INDmoney app.

What are the documents required to start investing in Vaxart stocks?

To start investing in Vaxart, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Vaxart?

Today's market capitalisation of Vaxart VXRT is 73.0M

Who is the Chief Executive Officer (CEO) of Vaxart ?

Mr. Steven Lo is the current Chief Executive Officer (CEO) of Vaxart.